Tamoxifen and endometrial neoplasia

被引:29
作者
Barakat, RR
机构
[1] c/o Academic Office, Department of Surgery, Mem. Sloan-Kettering Cancer Center, New York, NY 10021
关键词
D O I
10.1097/00003081-199609000-00012
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:629 / 640
页数:12
相关论文
共 36 条
[1]   GYNECOLOGIC EFFECTS OF TAMOXIFEN AND THE ASSOCIATION WITH ENDOMETRIAL CARCINOMA [J].
ASSIKIS, VJ ;
JORDAN, VC .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1995, 49 (03) :241-257
[2]   4 CASE-REPORTS PRESENTING NEW ACQUISITIONS ON THE ASSOCIATION BETWEEN BREAST AND ENDOMETRIAL CARCINOMA [J].
ATLANTE, G ;
POZZI, M ;
VINCENZONI, C ;
VOCATURO, G .
GYNECOLOGIC ONCOLOGY, 1990, 37 (03) :378-380
[3]   TAMOXIFEN USE IN BREAST-CANCER PATIENTS WHO SUBSEQUENTLY DEVELOP CORPUS CANCER IS NOT ASSOCIATED WITH A HIGHER INCIDENCE OF ADVERSE HISTOLOGIC FEATURES [J].
BARAKAT, RR ;
WONG, G ;
CURTIN, JP ;
VLAMIS, V ;
HOSKINS, WJ .
GYNECOLOGIC ONCOLOGY, 1994, 55 (02) :164-168
[4]  
BARAKAT RR, 1996, IN PRESS SOC GYN ONC
[5]  
BARAKAT RR, 1995, P ASCO, P779
[6]  
BOCCARDO F, 1981, ONCOLOGY, V38, P281, DOI 10.1159/000225571
[7]  
CORLEY D, 1992, OBSTET GYNECOL, V79, P111
[8]   CLINICAL AND PATHOLOGICAL FEATURES AND SURVIVAL OF ENDOMETRIAL CANCER-PATIENTS IN RELATION TO PRIOR USE OF ESTROGENS [J].
ELWOOD, JM ;
BOYES, DA .
GYNECOLOGIC ONCOLOGY, 1980, 10 (02) :173-187
[9]   ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14 [J].
FISHER, B ;
COSTANTINO, JP ;
REDMOND, CK ;
FISHER, ER ;
WICKERHAM, DL ;
CRONIN, WM ;
BOWMAN, D ;
COUTURE, J ;
DIMITROV, NV ;
EVANS, J ;
FARRAR, W ;
KAVANAH, M ;
LICKLEY, HL ;
MARGOLESE, R ;
PATERSON, AHG ;
ROBIDOUX, A ;
SHIBATA, H ;
TERZ, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07) :527-537
[10]   DESCRIPTIVE CLINICOPATHOLOGICAL STUDY OF 17 PATIENTS WITH ENDOMETRIAL CANCER DURING OR AFTER ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER [J].
FORNANDER, T ;
HELLSTROM, AC ;
MOBERGER, B .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (22) :1850-1855